UK

A version of this blog first appeared on Left Foot Forward

GW Pharmaceuticals' growing facility. (Image: GW Pharmaceuticals)

 

Judging by its contribution to the UN General Assembly Special Session on drugs, the UK has a long way to go if it's to catch up with progressive reform countries like Canada.
The Liberal Democrats have released the report of the expert panel they set up to look into the issue cannabis regulation.
The Home Affairs Select Committee has today released a report criticising the government for the way it is introducing its legislation on new psychoactive substances (so-called "legal highs"), and for its failure to look at evidence from other countries that have tried blanket bans like the one being implemented in the UK.
The issue of cannabis law reform dominated the news yesterday. The Liberal Democrats kicked off the day by announcing that they will set up an expert panel to look into how a legally regulated cannabis market could work in the UK.
As reported yesterday, the Treasury has produced a detailed cost-benefit analysis of establishing a legally regulated cannabis market in the UK. The report is largely based on existing research (PDF) carried out by the Beckley Foundation and the Institute for Social and Economic Research at the University of Essex and the, but updates and critiques some of that analysis.

Pages